BOSTON SCIENTIFIC ACKNOWLEDGES RISKS TIED TO STENT

Boston Scientific Corp. says a new internal analysis of its clinical data confirms an increased risk of blood clots with its drug-coated cardiac stent.

The Wall Street Journal (http://online.wsj.com/article_print/SB115759122980255909.html)